Chiara Cannatá

The BRD4S-LOXL2-MED1 interaction at the forefront of cell cycle transcriptional control in triple-negative breast cancer

Lorena Espinar, J. Arribas, L. Serrano, 2022, bioRxiv.

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

S. Sdelci, Anestis Gkanogiannis, Chiara Cannatá, 2023, EMBO molecular medicine.